You are here

Article Text

Article menu
Download PDFPDF
Viewpoint
C reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven
  1. S Kennon1,
  2. A D Timmis1,
  3. R Whitbourn2,
  4. C Knight1
  1. 1Department of Cardiology, Bart’s and the London NHS Trust, London, UK
  2. 2Department of Cardiology, St Vincent’s Hospital, Melbourne, Australia
  1. Correspondence to:
    Dr Simon Kennon, Department of Cardiology, London Chest Hospital, Bonner Road, London E2 9JX, UK;
    srok{at}dircon.co.uk

Abstract

Although C reactive protein is intimately involved with the pathogenic mechanisms that drive acute coronary syndromes, there is no evidence that it is helpful for identifying patient groups who might benefit from particular treatment strategies

  • C reactive protein
  • inflammation
  • acute coronary syndromes
  • troponin
  • CAPTURE, chimeric 7E3 antiplatelet therapy in unstable angina refractory to standard treatment
  • CRP, C reactive protein
  • FRISC, Fragmin during instability in coronary artery disease
  • IL, interleukin
  • TIMI, thrombolysis in myocardial infarction

https://doi.org/10.1136/heart.89.11.1288

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Linked Articles

    • Miscellanea
      WEB TOP 10
      BMJ Publishing Group Ltd and British Cardiovascular Society
      Heart 2004; 90 214-214 Published Online First: 16 Jan 2004.